The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biomarker Testing Services Market Research Report 2025
Synopsis
Biomarker testing services help evaluate molecular pathways leading to diseases, and biomarkers assay development helps in target identification and mechanism of action (MOA). In preclinical development, biomarker assay testing enables dose selection, MOA, and safety assessment.
Highlights
The global Biomarker Testing Services market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Biomarker Testing Services is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Biomarker Testing Services is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Biomarker Testing Services in Pharmaceutical and biotechnology companies is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Biomarker Testing Services include BioAgilytix Labs, Eurofins Scientific, SGS SA, Charles River Laboratories, Labcorp Drug Development, Thermo Fisher Scientific Inc.(PPD, Inc.), ICON Plc, IQVIA and Syneos Health, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Biomarker Assay Development, which accounted for % of the global market of Biomarker Testing Services in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biomarker Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker Testing Services.
The Biomarker Testing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Biomarker Testing Services market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarker Testing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
BioAgilytix Labs
Eurofins Scientific
SGS SA
Charles River Laboratories
Labcorp Drug Development
Thermo Fisher Scientific Inc.(PPD, Inc.)
ICON Plc
IQVIA
Syneos Health
Intertek Group Plc
ACM Global Laboratories
Ardena
Cerba Research
Svar Life Science
ABL, Inc.
Product Type Insights
Global markets are presented by Biomarker Testing Services type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Biomarker Testing Services are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Biomarker Testing Services segment by Type
Biomarker Assay Development
Flow Cytometry
Others
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Biomarker Testing Services market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Biomarker Testing Services market.
Biomarker Testing Services Segment by End User
Pharmaceutical and biotechnology companies
Research Institutes
CRO
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Biomarker Testing Services market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomarker Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Biomarker Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Biomarker Testing Services industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomarker Testing Services.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomarker Testing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Biomarker testing services help evaluate molecular pathways leading to diseases, and biomarkers assay development helps in target identification and mechanism of action (MOA). In preclinical development, biomarker assay testing enables dose selection, MOA, and safety assessment.
Highlights
The global Biomarker Testing Services market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Biomarker Testing Services is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Biomarker Testing Services is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Biomarker Testing Services in Pharmaceutical and biotechnology companies is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Biomarker Testing Services include BioAgilytix Labs, Eurofins Scientific, SGS SA, Charles River Laboratories, Labcorp Drug Development, Thermo Fisher Scientific Inc.(PPD, Inc.), ICON Plc, IQVIA and Syneos Health, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Biomarker Assay Development, which accounted for % of the global market of Biomarker Testing Services in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biomarker Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker Testing Services.
The Biomarker Testing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Biomarker Testing Services market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarker Testing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
BioAgilytix Labs
Eurofins Scientific
SGS SA
Charles River Laboratories
Labcorp Drug Development
Thermo Fisher Scientific Inc.(PPD, Inc.)
ICON Plc
IQVIA
Syneos Health
Intertek Group Plc
ACM Global Laboratories
Ardena
Cerba Research
Svar Life Science
ABL, Inc.
Product Type Insights
Global markets are presented by Biomarker Testing Services type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Biomarker Testing Services are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Biomarker Testing Services segment by Type
Biomarker Assay Development
Flow Cytometry
Others
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Biomarker Testing Services market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Biomarker Testing Services market.
Biomarker Testing Services Segment by End User
Pharmaceutical and biotechnology companies
Research Institutes
CRO
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Biomarker Testing Services market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomarker Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Biomarker Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Biomarker Testing Services industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomarker Testing Services.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomarker Testing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarker Testing Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Biomarker Assay Development
1.2.3 Flow Cytometry
1.2.4 Others
1.3 Market by End User
1.3.1 Global Biomarker Testing Services Market Share by End User: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical and biotechnology companies
1.3.3 Research Institutes
1.3.4 CRO
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biomarker Testing Services Market Perspective (2017-2028)
2.2 Biomarker Testing Services Growth Trends by Region
2.2.1 Biomarker Testing Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biomarker Testing Services Historic Market Size by Region (2017-2022)
2.2.3 Biomarker Testing Services Forecasted Market Size by Region (2023-2028)
2.3 Biomarker Testing Services Market Dynamics
2.3.1 Biomarker Testing Services Industry Trends
2.3.2 Biomarker Testing Services Market Drivers
2.3.3 Biomarker Testing Services Market Challenges
2.3.4 Biomarker Testing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomarker Testing Services Players by Revenue
3.1.1 Global Top Biomarker Testing Services Players by Revenue (2017-2022)
3.1.2 Global Biomarker Testing Services Revenue Market Share by Players (2017-2022)
3.2 Global Biomarker Testing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biomarker Testing Services Revenue
3.4 Global Biomarker Testing Services Market Concentration Ratio
3.4.1 Global Biomarker Testing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarker Testing Services Revenue in 2021
3.5 Biomarker Testing Services Key Players Head office and Area Served
3.6 Key Players Biomarker Testing Services Product Solution and Service
3.7 Date of Enter into Biomarker Testing Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomarker Testing Services Breakdown Data by Type
4.1 Global Biomarker Testing Services Historic Market Size by Type (2017-2022)
4.2 Global Biomarker Testing Services Forecasted Market Size by Type (2023-2028)
5 Biomarker Testing Services Breakdown Data by End User
5.1 Global Biomarker Testing Services Historic Market Size by End User (2017-2022)
5.2 Global Biomarker Testing Services Forecasted Market Size by End User (2023-2028)
6 North America
6.1 North America Biomarker Testing Services Market Size (2017-2028)
6.2 North America Biomarker Testing Services Market Size by Country (2017-2022)
6.3 North America Biomarker Testing Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Biomarker Testing Services Market Size (2017-2028)
7.2 Europe Biomarker Testing Services Market Size by Country (2017-2022)
7.3 Europe Biomarker Testing Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomarker Testing Services Market Size (2017-2028)
8.2 Asia-Pacific Biomarker Testing Services Market Size by Country (2017-2022)
8.3 Asia-Pacific Biomarker Testing Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Biomarker Testing Services Market Size (2017-2028)
9.2 Latin America Biomarker Testing Services Market Size by Country (2017-2022)
9.3 Latin America Biomarker Testing Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomarker Testing Services Market Size (2017-2028)
10.2 Middle East & Africa Biomarker Testing Services Market Size by Country (2017-2022)
10.3 Middle East & Africa Biomarker Testing Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 BioAgilytix Labs
11.1.1 BioAgilytix Labs Company Detail
11.1.2 BioAgilytix Labs Business Overview
11.1.3 BioAgilytix Labs Biomarker Testing Services Introduction
11.1.4 BioAgilytix Labs Revenue in Biomarker Testing Services Business (2017-2022)
11.1.5 BioAgilytix Labs Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Detail
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Biomarker Testing Services Introduction
11.2.4 Eurofins Scientific Revenue in Biomarker Testing Services Business (2017-2022)
11.2.5 Eurofins Scientific Recent Development
11.3 SGS SA
11.3.1 SGS SA Company Detail
11.3.2 SGS SA Business Overview
11.3.3 SGS SA Biomarker Testing Services Introduction
11.3.4 SGS SA Revenue in Biomarker Testing Services Business (2017-2022)
11.3.5 SGS SA Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Detail
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Biomarker Testing Services Introduction
11.4.4 Charles River Laboratories Revenue in Biomarker Testing Services Business (2017-2022)
11.4.5 Charles River Laboratories Recent Development
11.5 Labcorp Drug Development
11.5.1 Labcorp Drug Development Company Detail
11.5.2 Labcorp Drug Development Business Overview
11.5.3 Labcorp Drug Development Biomarker Testing Services Introduction
11.5.4 Labcorp Drug Development Revenue in Biomarker Testing Services Business (2017-2022)
11.5.5 Labcorp Drug Development Recent Development
11.6 Thermo Fisher Scientific Inc.(PPD, Inc.)
11.6.1 Thermo Fisher Scientific Inc.(PPD, Inc.) Company Detail
11.6.2 Thermo Fisher Scientific Inc.(PPD, Inc.) Business Overview
11.6.3 Thermo Fisher Scientific Inc.(PPD, Inc.) Biomarker Testing Services Introduction
11.6.4 Thermo Fisher Scientific Inc.(PPD, Inc.) Revenue in Biomarker Testing Services Business (2017-2022)
11.6.5 Thermo Fisher Scientific Inc.(PPD, Inc.) Recent Development
11.7 ICON Plc
11.7.1 ICON Plc Company Detail
11.7.2 ICON Plc Business Overview
11.7.3 ICON Plc Biomarker Testing Services Introduction
11.7.4 ICON Plc Revenue in Biomarker Testing Services Business (2017-2022)
11.7.5 ICON Plc Recent Development
11.8 IQVIA
11.8.1 IQVIA Company Detail
11.8.2 IQVIA Business Overview
11.8.3 IQVIA Biomarker Testing Services Introduction
11.8.4 IQVIA Revenue in Biomarker Testing Services Business (2017-2022)
11.8.5 IQVIA Recent Development
11.9 Syneos Health
11.9.1 Syneos Health Company Detail
11.9.2 Syneos Health Business Overview
11.9.3 Syneos Health Biomarker Testing Services Introduction
11.9.4 Syneos Health Revenue in Biomarker Testing Services Business (2017-2022)
11.9.5 Syneos Health Recent Development
11.10 Intertek Group Plc
11.10.1 Intertek Group Plc Company Detail
11.10.2 Intertek Group Plc Business Overview
11.10.3 Intertek Group Plc Biomarker Testing Services Introduction
11.10.4 Intertek Group Plc Revenue in Biomarker Testing Services Business (2017-2022)
11.10.5 Intertek Group Plc Recent Development
11.11 ACM Global Laboratories
11.11.1 ACM Global Laboratories Company Detail
11.11.2 ACM Global Laboratories Business Overview
11.11.3 ACM Global Laboratories Biomarker Testing Services Introduction
11.11.4 ACM Global Laboratories Revenue in Biomarker Testing Services Business (2017-2022)
11.11.5 ACM Global Laboratories Recent Development
11.12 Ardena
11.12.1 Ardena Company Detail
11.12.2 Ardena Business Overview
11.12.3 Ardena Biomarker Testing Services Introduction
11.12.4 Ardena Revenue in Biomarker Testing Services Business (2017-2022)
11.12.5 Ardena Recent Development
11.13 Cerba Research
11.13.1 Cerba Research Company Detail
11.13.2 Cerba Research Business Overview
11.13.3 Cerba Research Biomarker Testing Services Introduction
11.13.4 Cerba Research Revenue in Biomarker Testing Services Business (2017-2022)
11.13.5 Cerba Research Recent Development
11.14 Svar Life Science
11.14.1 Svar Life Science Company Detail
11.14.2 Svar Life Science Business Overview
11.14.3 Svar Life Science Biomarker Testing Services Introduction
11.14.4 Svar Life Science Revenue in Biomarker Testing Services Business (2017-2022)
11.14.5 Svar Life Science Recent Development
11.15 ABL, Inc.
11.15.1 ABL, Inc. Company Detail
11.15.2 ABL, Inc. Business Overview
11.15.3 ABL, Inc. Biomarker Testing Services Introduction
11.15.4 ABL, Inc. Revenue in Biomarker Testing Services Business (2017-2022)
11.15.5 ABL, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Biomarker Testing Services Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Biomarker Assay Development
Table 3. Key Players of Flow Cytometry
Table 4. Key Players of Others
Table 5. Global Biomarker Testing Services Market Size Growth by End User (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Biomarker Testing Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Biomarker Testing Services Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Biomarker Testing Services Market Share by Region (2017-2022)
Table 9. Global Biomarker Testing Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Biomarker Testing Services Market Share by Region (2023-2028)
Table 11. Biomarker Testing Services Market Trends
Table 12. Biomarker Testing Services Market Drivers
Table 13. Biomarker Testing Services Market Challenges
Table 14. Biomarker Testing Services Market Restraints
Table 15. Global Biomarker Testing Services Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Biomarker Testing Services Market Share by Players (2017-2022)
Table 17. Global Top Biomarker Testing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Testing Services as of 2021)
Table 18. Ranking of Global Top Biomarker Testing Services Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Biomarker Testing Services Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biomarker Testing Services Product Solution and Service
Table 22. Date of Enter into Biomarker Testing Services Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biomarker Testing Services Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Biomarker Testing Services Revenue Market Share by Type (2017-2022)
Table 26. Global Biomarker Testing Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Biomarker Testing Services Revenue Market Share by Type (2023-2028)
Table 28. Global Biomarker Testing Services Market Size by End User (2017-2022) & (US$ Million)
Table 29. Global Biomarker Testing Services Revenue Market Share by End User (2017-2022)
Table 30. Global Biomarker Testing Services Forecasted Market Size by End User (2023-2028) & (US$ Million)
Table 31. Global Biomarker Testing Services Revenue Market Share by End User (2023-2028)
Table 32. North America Biomarker Testing Services Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Biomarker Testing Services Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Biomarker Testing Services Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Biomarker Testing Services Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Biomarker Testing Services Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Biomarker Testing Services Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Biomarker Testing Services Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Biomarker Testing Services Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Biomarker Testing Services Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Biomarker Testing Services Market Size by Country (2023-2028) & (US$ Million)
Table 42. BioAgilytix Labs Company Detail
Table 43. BioAgilytix Labs Business Overview
Table 44. BioAgilytix Labs Biomarker Testing Services Product
Table 45. BioAgilytix Labs Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 46. BioAgilytix Labs Recent Development
Table 47. Eurofins Scientific Company Detail
Table 48. Eurofins Scientific Business Overview
Table 49. Eurofins Scientific Biomarker Testing Services Product
Table 50. Eurofins Scientific Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 51. Eurofins Scientific Recent Development
Table 52. SGS SA Company Detail
Table 53. SGS SA Business Overview
Table 54. SGS SA Biomarker Testing Services Product
Table 55. SGS SA Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 56. SGS SA Recent Development
Table 57. Charles River Laboratories Company Detail
Table 58. Charles River Laboratories Business Overview
Table 59. Charles River Laboratories Biomarker Testing Services Product
Table 60. Charles River Laboratories Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 61. Charles River Laboratories Recent Development
Table 62. Labcorp Drug Development Company Detail
Table 63. Labcorp Drug Development Business Overview
Table 64. Labcorp Drug Development Biomarker Testing Services Product
Table 65. Labcorp Drug Development Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 66. Labcorp Drug Development Recent Development
Table 67. Thermo Fisher Scientific Inc.(PPD, Inc.) Company Detail
Table 68. Thermo Fisher Scientific Inc.(PPD, Inc.) Business Overview
Table 69. Thermo Fisher Scientific Inc.(PPD, Inc.) Biomarker Testing Services Product
Table 70. Thermo Fisher Scientific Inc.(PPD, Inc.) Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 71. Thermo Fisher Scientific Inc.(PPD, Inc.) Recent Development
Table 72. ICON Plc Company Detail
Table 73. ICON Plc Business Overview
Table 74. ICON Plc Biomarker Testing Services Product
Table 75. ICON Plc Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 76. ICON Plc Recent Development
Table 77. IQVIA Company Detail
Table 78. IQVIA Business Overview
Table 79. IQVIA Biomarker Testing Services Product
Table 80. IQVIA Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 81. IQVIA Recent Development
Table 82. Syneos Health Company Detail
Table 83. Syneos Health Business Overview
Table 84. Syneos Health Biomarker Testing Services Product
Table 85. Syneos Health Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 86. Syneos Health Recent Development
Table 87. Intertek Group Plc Company Detail
Table 88. Intertek Group Plc Business Overview
Table 89. Intertek Group Plc Biomarker Testing Services Product
Table 90. Intertek Group Plc Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 91. Intertek Group Plc Recent Development
Table 92. ACM Global Laboratories Company Detail
Table 93. ACM Global Laboratories Business Overview
Table 94. ACM Global Laboratories Biomarker Testing ServicesProduct
Table 95. ACM Global Laboratories Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 96. ACM Global Laboratories Recent Development
Table 97. Ardena Company Detail
Table 98. Ardena Business Overview
Table 99. Ardena Biomarker Testing ServicesProduct
Table 100. Ardena Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 101. Ardena Recent Development
Table 102. Cerba Research Company Detail
Table 103. Cerba Research Business Overview
Table 104. Cerba Research Biomarker Testing ServicesProduct
Table 105. Cerba Research Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 106. Cerba Research Recent Development
Table 107. Svar Life Science Company Detail
Table 108. Svar Life Science Business Overview
Table 109. Svar Life Science Biomarker Testing ServicesProduct
Table 110. Svar Life Science Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 111. Svar Life Science Recent Development
Table 112. ABL, Inc. Company Detail
Table 113. ABL, Inc. Business Overview
Table 114. ABL, Inc. Biomarker Testing ServicesProduct
Table 115. ABL, Inc. Revenue in Biomarker Testing Services Business (2017-2022) & (US$ Million)
Table 116. ABL, Inc. Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biomarker Testing Services Market Share by Type: 2021 VS 2028
Figure 2. Biomarker Assay Development Features
Figure 3. Flow Cytometry Features
Figure 4. Others Features
Figure 5. Global Biomarker Testing Services Market Share by End User in 2021 & 2028
Figure 6. Pharmaceutical and biotechnology companies Case Studies
Figure 7. Research Institutes Case Studies
Figure 8. CRO Case Studies
Figure 9. Biomarker Testing Services Report Years Considered
Figure 10. Global Biomarker Testing Services Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Biomarker Testing Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Biomarker Testing Services Market Share by Region: 2021 VS 2028
Figure 13. Global Biomarker Testing Services Market Share by Players in 2021
Figure 14. Global Top Biomarker Testing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Testing Services as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Biomarker Testing Services Revenue in 2021
Figure 16. North America Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Biomarker Testing Services Market Share by Country (2017-2028)
Figure 18. United States Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Biomarker Testing Services Market Share by Country (2017-2028)
Figure 22. Germany Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Biomarker Testing Services Market Share by Region (2017-2028)
Figure 30. China Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Biomarker Testing Services Market Share by Country (2017-2028)
Figure 38. Mexico Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Biomarker Testing Services Market Share by Country (2017-2028)
Figure 42. Turkey Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Biomarker Testing Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. BioAgilytix Labs Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 45. Eurofins Scientific Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 46. SGS SA Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 47. Charles River Laboratories Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 48. Labcorp Drug Development Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 49. Thermo Fisher Scientific Inc.(PPD, Inc.) Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 50. ICON Plc Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 51. IQVIA Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 52. Syneos Health Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 53. Intertek Group Plc Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 54. ACM Global Laboratories Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 55. Ardena Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 56. Cerba Research Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 57. Svar Life Science Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 58. ABL, Inc. Revenue Growth Rate in Biomarker Testing Services Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
